RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 31, 16:00
RVL Pharmaceuticals Cash from Financing (Quarterly): -0.46M for June 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.46M |
| March 31, 2023 | -4.86M |
| December 31, 2022 | 1.396M |
| September 30, 2022 | 42.20M |
| June 30, 2022 | -0.981M |
| March 31, 2022 | -0.837M |
| December 31, 2021 | 56.56M |
| September 30, 2021 | -186.10M |
| June 30, 2021 | -5.559M |
| March 31, 2021 | -0.236M |
| December 31, 2020 | -3.076M |
| Date | Value |
|---|---|
| September 30, 2020 | -23.13M |
| June 30, 2020 | -1.085M |
| March 31, 2020 | 30.98M |
| December 31, 2019 | -1.879M |
| September 30, 2019 | -1.965M |
| June 30, 2019 | 0.163M |
| March 31, 2019 | -1.01M |
| December 31, 2018 | 9.338M |
| September 30, 2018 | -2.363M |
| June 30, 2018 | -1.294M |
| March 31, 2018 | -2.076M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-186.10M
Minimum
Sep 2021
56.56M
Maximum
Dec 2021
-5.816M
Average
-0.981M
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 5.025M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | 1.653M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.06M |
| Cash from Investing (Quarterly) | -0.959M |
| Free Cash Flow | -47.48M |
| Free Cash Flow Per Share (Quarterly) | -0.1319 |
| Free Cash Flow to Equity (Quarterly) | -13.67M |
| Free Cash Flow to Firm (Quarterly) | -9.966M |